Peptide record

TPDB01014

ACE inhibitor ACE inhibitors Antihypertensive Antioxidant standard
3 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB01014
ACE inhibitor
ACE inhibitors Antihypertensive Antioxidant
Cardiometabolic peptides Functional / health-promoting peptides
Peptipedia AHTPDB AHTpin AnOxPePred - 1.0 Multi-AOP
standard
No
A 3-aa standard-residue multi-activity (ACE inhibitors, Antihypertensive, and Antioxidant) peptide sequence curated from Peptipedia, AHTPDB, AHTpin, and other sources, with an available 3D structural model.
Sequence
LEK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C17H32N4O6
ARNDCQGHIMFPSTWYV
ELK
388.46
6.94
1
1
1
-0
2.48
-1.200
130.00
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
1
E
0
Q
0
G
0
H
0
I
1
L
1
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
3 reviewed residue count
C17H32N4O6 sequence-only estimate (linear, free termini)
388.46 sequence-only estimate (linear, free termini)
6.94 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
2.48 sequence-only estimate (linear, free termini)
-1.200 sequence-only estimate (linear, free termini)
388.4579 Activity
388.2314 Activity
Evidence Records 3 records
Evidence 1 Activity

Activity

EC50
ACE inhibitors
794.40 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

NA
Wu J., Aluko R. E., Nakai S.
Structural requirements of angiotensin I-converting enzyme inhibitory activity: quantitative structure-activity relationship study of di- and tripeptides. J. Agric. Food Chem., 54, 732-738, 2006
2006
Journal

Other

3
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CCCCN)C(=O)O InChI=1S/C17H32N4O6/c1-10(2)9-11(19)15(24)20-12(6-7-14(22)23)16(25)21-13(17(26)27)5-3-4-8-18/h10-13H,3-9,18-19H2,1-2H3,(H,20,24)(H,21,25)(H,22,23)(H,26,27)/t11-,12-,13-/m0/s1 InChIKey: HQUXQAMSWFIRET-AVGNSLFASA-N Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: M02-001
Evidence 2 Activity

Activity

EC50
Antihypertensive
794.40 µM
Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)
ACE inhibitor
ah

Source & Reference

AHTPDB
Wu J., Aluko R. E., Nakai S.
Structural requirements of angiotensin I-converting enzyme inhibitory activity: quantitative structure-activity relationship study of di- and tripeptides. J. Agric. Food Chem., 54, 732-738, 2006
2006
Journal

Other

Source Activity Label Source Definition
Antihypertensive
AHTPDB manually curated experimentally validated antihypertensive peptide annotation.
3
BIOPEP-UWM database of bioactive peptides SMILES: N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N[C@@]([H])(CCCCN)C(=O)O InChI=1S/C17H32N4O6/c1-10(2)9-11(19)15(24)20-12(6-7-14(22)23)16(25)21-13(17(26)27)5-3-4-8-18/h10-13H,3-9,18-19H2,1-2H3,(H,20,24)(H,21,25)(H,22,23)(H,26,27)/t11-,12-,13-/m0/s1 InChIKey: HQUXQAMSWFIRET-AVGNSLFASA-N Information concerning Angiotensin-Converting Enzyme (ACE) is available in MEROPS database of proteolytic enzymes (http://merops.sanger.ac.uk/) ID: M02-001
Evidence 3 Activity

Activity

Antioxidative activity
Antioxidant

Source & Reference

NA
DFBP
Additional Detail Fields 1 fields
3